Diseases of Unstable Repeat Expansion: Mechanisms and Common Principles

[1]  K. Fischbeck,et al.  Therapeutics development for triplet repeat expansion diseases , 2005, Nature Reviews Genetics.

[2]  Juan Botas,et al.  The AXH Domain of Ataxin-1 Mediates Neurodegeneration through Its Interaction with Gfi-1/Senseless Proteins , 2005, Cell.

[3]  M. Hayden,et al.  Absence of behavioral abnormalities and neurodegeneration in vivo despite widespread neuronal huntingtin inclusions. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[4]  R. Frank Kooy,et al.  Cognitive decline, neuromotor and behavioural disturbances in a mouse model for fragile-X-associated tremor/ataxia syndrome (FXTAS) , 2005, Behavioural Brain Research.

[5]  R. Schekman.  Peroxisomes: Another Branch of the Secretory Pathway? , 2005, Cell.

[6]  T. Cooper,et al.  Colocalization of muscleblind with RNA foci is separable from mis-regulation of alternative splicing in myotonic dystrophy , 2005, Journal of Cell Science.

[7]  B. Chait,et al.  Polyglutamine-expanded ataxin-7 inhibits STAGA histone acetyltransferase activity to produce retinal degeneration. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[8]  J. Yates,et al.  Polyglutamine-expanded spinocerebellar ataxia-7 protein disrupts normal SAGA and SLIK histone acetyltransferase activity. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[9]  T. Cooper,et al.  Transgenic mice expressing CUG-BP1 reproduce splicing mis-regulation observed in myotonic dystrophy. , 2005, Human molecular genetics.

[10]  S. Eddy,et al.  Kissing complex RNAs mediate interaction between the Fragile-X mental retardation protein KH2 domain and brain polyribosomes. , 2005, Genes & development.

[11]  H. Paulson,et al.  Ataxin-3 suppresses polyglutamine neurodegeneration in Drosophila by a ubiquitin-associated mechanism. , 2005, Molecular cell.

[12]  Yan Wang,et al.  Pharmacological Rescue of Synaptic Plasticity, Courtship Behavior, and Mushroom Body Defects in a Drosophila Model of Fragile X Syndrome , 2005, Neuron.

[13]  H. Zoghbi,et al.  Neuronal dysfunction in a polyglutamine disease model occurs in the absence of ubiquitin-proteasome system impairment and inversely correlates with the degree of nuclear inclusion formation. , 2005, Human molecular genetics.

[14]  R. Llinás,et al.  Disturbed Ca2+ signaling and apoptosis of medium spiny neurons in Huntington's disease. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[15]  M. Koenig,et al.  Friedreich ataxia: the oxidative stress paradox. , 2005, Human molecular genetics.

[16]  E. Bennett,et al.  Global impairment of the ubiquitin-proteasome system by nuclear or cytoplasmic protein aggregates precedes inclusion body formation. , 2005, Molecular cell.

[17]  M. Swanson,et al.  Myotonic dystrophy type 1 is associated with nuclear foci of mutant RNA, sequestration of muscleblind proteins and deregulated alternative splicing in neurons. , 2004, Human molecular genetics.

[18]  P. Jin,et al.  RNA and microRNAs in fragile X mental retardation , 2004, Nature Cell Biology.

[19]  Mark R. Segal,et al.  Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death , 2004, Nature.

[20]  Harry T Orr,et al.  Recovery from Polyglutamine-Induced Neurodegeneration in Conditional SCA1 Transgenic Mice , 2004, The Journal of Neuroscience.

[21]  L. Ranum,et al.  Pathogenic RNA repeats: an expanding role in genetic disease. , 2004, Trends in genetics : TIG.

[22]  T. Cooper,et al.  Muscleblind proteins regulate alternative splicing , 2004, The EMBO journal.

[23]  Peter Breuer,et al.  Cellular toxicity of polyglutamine expansion proteins: mechanism of transcription factor deactivation. , 2004, Molecular cell.

[24]  Mark F Bear,et al.  The mGluR theory of fragile X mental retardation , 2004, Trends in Neurosciences.

[25]  Brigitte Bogert,et al.  The fragile X-related Gene Affects the Crawling Behavior of Drosophila Larvae by Regulating the mRNA Level of the DEG/ENaC Protein Pickpocket1 , 2004, Current Biology.

[26]  J. Cowan,et al.  Frataxin-mediated Iron Delivery to Ferrochelatase in the Final Step of Heme Biosynthesis* , 2004, Journal of Biological Chemistry.

[27]  Christine Van Broeckhoven,et al.  Proteasome degrades soluble expanded polyglutamine completely and efficiently , 2004, Neurobiology of Disease.

[28]  Fumiaki Tanaka,et al.  Sodium butyrate ameliorates phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy. , 2004, Human molecular genetics.

[29]  Francesco Scaravilli,et al.  Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease , 2004, Nature Genetics.

[30]  K. Wilkinson,et al.  Modulating huntingtin half‐life alters polyglutamine‐dependent aggregate formation and cell toxicity , 2004, Journal of neurochemistry.

[31]  Ronald Wetzel,et al.  Eukaryotic proteasomes cannot digest polyglutamine sequences and release them during degradation of polyglutamine-containing proteins. , 2004, Molecular cell.

[32]  P. Pandolfi,et al.  SUMO Modification of Huntingtin and Huntington's Disease Pathology , 2004, Science.

[33]  Hung-Ying Kao,et al.  Ataxin 1, a SCA1 neurodegenerative disorder protein, is functionally linked to the silencing mediator of retinoid and thyroid hormone receptors , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[34]  M. Mutsuddi,et al.  The Spinocerebellar Ataxia 8 Noncoding RNA Causes Neurodegeneration and Associates with Staufen in Drosophila , 2004, Current Biology.

[35]  Daniela C. Zarnescu,et al.  Biochemical and genetic interaction between the fragile X mental retardation protein and the microRNA pathway , 2004, Nature Neuroscience.

[36]  M. Delatycki,et al.  Friedreich ataxia—update on pathogenesis and possible therapies , 2004, Neurogenetics.

[37]  R. P. Junghans,et al.  RNA Leaching of Transcription Factors Disrupts Transcription in Myotonic Dystrophy , 2004, Science.

[38]  W. Hauswirth,et al.  A Muscleblind Knockout Model for Myotonic Dystrophy , 2003, Science.

[39]  Fen-Biao Gao,et al.  Control of dendritic development by the Drosophila fragile X-related gene involves the small GTPase Rac1 , 2003, Development.

[40]  R. Margolis,et al.  Why is SCA12 different from other SCAs? , 2003, Cytogenetic and Genome Research.

[41]  Ruth Luthi-Carter,et al.  Histone Deacetylase Inhibition by Sodium Butyrate Chemotherapy Ameliorates the Neurodegenerative Phenotype in Huntington's Disease Mice , 2003, The Journal of Neuroscience.

[42]  Aaron Ciechanover,et al.  The Ubiquitin Proteasome System in Neurodegenerative Diseases Sometimes the Chicken, Sometimes the Egg , 2003, Neuron.

[43]  Scott T. Brady,et al.  Neuropathogenic Forms of Huntingtin and Androgen Receptor Inhibit Fast Axonal Transport , 2003, Neuron.

[44]  Richard G. Brusch,et al.  Disruption of Axonal Transport by Loss of Huntingtin or Expression of Pathogenic PolyQ Proteins in Drosophila , 2003, Neuron.

[45]  Peng Jin,et al.  RNA-Mediated Neurodegeneration Caused by the Fragile X Premutation rCGG Repeats in Drosophila , 2003, Neuron.

[46]  H. Zoghbi,et al.  Interaction of Akt-Phosphorylated Ataxin-1 with 14-3-3 Mediates Neurodegeneration in Spinocerebellar Ataxia Type 1 , 2003, Cell.

[47]  Effat S. Emamian,et al.  Serine 776 of Ataxin-1 Is Critical for Polyglutamine-Induced Disease in SCA1 Transgenic Mice , 2003, Neuron.

[48]  Mariette Schrier,et al.  The FMR1 CGG repeat mouse displays ubiquitin-positive intranuclear neuronal inclusions; implications for the cerebellar tremor/ataxia syndrome. , 2003, Human molecular genetics.

[49]  J. Cowan,et al.  Iron-sulfur cluster biosynthesis. Characterization of frataxin as an iron donor for assembly of [2Fe-2S] clusters in ISU-type proteins. , 2003, Journal of the American Chemical Society.

[50]  W. Brown,et al.  Fragile X premutation tremor/ataxia syndrome: molecular, clinical, and neuroimaging correlates. , 2003, American journal of human genetics.

[51]  Leslie M Thompson,et al.  Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[52]  Edwin J. Weeber,et al.  SCA7 Knockin Mice Model Human SCA7 and Reveal Gradual Accumulation of Mutant Ataxin-7 in Neurons and Abnormalities in Short-Term Plasticity , 2003, Neuron.

[53]  P. Hagerman,et al.  Reduced FMR1 mRNA translation efficiency in fragile X patients with premutations. , 2002, RNA.

[54]  K. Lindsten,et al.  Aggregate formation inhibits proteasomal degradation of polyglutamine proteins. , 2002, Human molecular genetics.

[55]  A. Caudy,et al.  Fragile X-related protein and VIG associate with the RNA interference machinery. , 2002, Genes & development.

[56]  M. Siomi,et al.  A Drosophila fragile X protein interacts with components of RNAi and ribosomal proteins. , 2002, Genes & development.

[57]  B. Schmidt,et al.  Expression of X-linked bulbospinal muscular atrophy (Kennedy disease) in two homozygous women. , 2002, Neurology.

[58]  T. Tabata,et al.  Androgen-Dependent Neurodegeneration by Polyglutamine-Expanded Human Androgen Receptor in Drosophila , 2002, Neuron.

[59]  G. Sobue,et al.  Testosterone Reduction Prevents Phenotypic Expression in a Transgenic Mouse Model of Spinal and Bulbar Muscular Atrophy , 2002, Neuron.

[60]  M. Ristow,et al.  The yeast frataxin homolog Yfh1p plays a specific role in the maturation of cellular Fe/S proteins. , 2002, Human molecular genetics.

[61]  James R. Burke,et al.  Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines , 2002, Nature Neuroscience.

[62]  M. D. Del Bigio,et al.  Neuronal intranuclear inclusions in a new cerebellar tremor/ataxia syndrome among fragile X carriers. , 2002, Brain : a journal of neurology.

[63]  S. Cannon,et al.  Expanded CUG repeats trigger aberrant splicing of ClC-1 chloride channel pre-mRNA and hyperexcitability of skeletal muscle in myotonic dystrophy. , 2002, Molecular cell.

[64]  T. Cooper,et al.  Loss of the muscle-specific chloride channel in type 1 myotonic dystrophy due to misregulated alternative splicing. , 2002, Molecular cell.

[65]  H. Zoghbi,et al.  A Long CAG Repeat in the Mouse Sca1 Locus Replicates SCA1 Features and Reveals the Impact of Protein Solubility on Selective Neurodegeneration , 2002, Neuron.

[66]  Mark F. Bear,et al.  Altered synaptic plasticity in a mouse model of fragile X mental retardation , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[67]  Dimitri Krainc,et al.  Sp1 and TAFII130 Transcriptional Activity Disrupted in Early Huntington's Disease , 2002, Science.

[68]  Zhao-Xue Yu,et al.  Huntingtin inclusions do not deplete polyglutamine-containing transcription factors in HD mice. , 2002, Human molecular genetics.

[69]  P. Harper,et al.  Three proteins, MBNL, MBLL and MBXL, co-localize in vivo with nuclear foci of expanded-repeat transcripts in DM1 and DM2 cells. , 2002, Human molecular genetics.

[70]  H. Zoghbi,et al.  Impaired Conditioned Fear and Enhanced Long-Term Potentiation inFmr2 Knock-Out Mice , 2002, The Journal of Neuroscience.

[71]  He Li,et al.  Interaction of Huntington Disease Protein with Transcriptional Activator Sp1 , 2002, Molecular and Cellular Biology.

[72]  Tian Xu,et al.  Drosophila Atrophin Homolog Functions as a Transcriptional Corepressor in Multiple Developmental Processes , 2002, Cell.

[73]  K. Fischbeck,et al.  Histone deacetylase inhibitors reduce polyglutamine toxicity , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[74]  Gerald M. Rubin,et al.  Drosophila Fragile X-Related Gene Regulates the MAP1B Homolog Futsch to Control Synaptic Structure and Function , 2001, Cell.

[75]  J. Darnell,et al.  Microarray Identification of FMRP-Associated Brain mRNAs and Altered mRNA Translational Profiles in Fragile X Syndrome , 2001, Cell.

[76]  J. Darnell,et al.  Fragile X Mental Retardation Protein Targets G Quartet mRNAs Important for Neuronal Function , 2001, Cell.

[77]  D. Housman,et al.  Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila , 2001, Nature.

[78]  A. Munnich,et al.  Disabled early recruitment of antioxidant defenses in Friedreich's ataxia. , 2001, Human molecular genetics.

[79]  C. Ehresmann,et al.  The fragile X mental retardation protein binds specifically to its mRNA via a purine quartet motif , 2001, The EMBO journal.

[80]  T. Cooper,et al.  Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy , 2001, Nature Genetics.

[81]  S. Naylor,et al.  Myotonic Dystrophy Type 2 Caused by a CCTG Expansion in Intron 1 of ZNF9 , 2001, Science.

[82]  I. Kanazawa,et al.  SCA17, a novel autosomal dominant cerebellar ataxia caused by an expanded polyglutamine in TATA-binding protein. , 2001, Human molecular genetics.

[83]  H. Zoghbi,et al.  Over-expression of inducible HSP70 chaperone suppresses neuropathology and improves motor function in SCA1 mice. , 2001, Human molecular genetics.

[84]  Blair R. Leavitt,et al.  Loss of Huntingtin-Mediated BDNF Gene Transcription in Huntington's Disease , 2001, Science.

[85]  S. Warren,et al.  The fragile X mental retardation protein inhibits translation via interacting with mRNA. , 2001, Nucleic acids research.

[86]  C A Ross,et al.  Interference by Huntingtin and Atrophin-1 with CBP-Mediated Transcription Leading to Cellular Toxicity , 2001, Science.

[87]  T. Ashizawa,et al.  RNA CUG Repeats Sequester CUGBP1 and Alter Protein Levels and Activity of CUGBP1* , 2001, The Journal of Biological Chemistry.

[88]  E. Hafen,et al.  Lilliputian: an AF4/FMR2-related protein that controls cell identity and cell growth. , 2001, Development.

[89]  A. Ostareck-Lederer,et al.  Evidence that fragile X mental retardation protein is a negative regulator of translation. , 2001, Human molecular genetics.

[90]  S. Newfeld,et al.  A screen for modifiers of decapentaplegic mutant phenotypes identifies lilliputian, the only member of the Fragile-X/Burkitt's Lymphoma family of transcription factors in Drosophila melanogaster. , 2001, Genetics.

[91]  J. Melki,et al.  Mouse models for Friedreich ataxia exhibit cardiomyopathy, sensory nerve defect and Fe-S enzyme deficiency followed by intramitochondrial iron deposits , 2001, Nature Genetics.

[92]  I. Weiler,et al.  Abnormal dendritic spine characteristics in the temporal and visual cortices of patients with fragile-X syndrome: a quantitative examination. , 2001, American journal of medical genetics.

[93]  M. Emond,et al.  Increased levels of plasma malondialdehyde in Friedreich ataxia. , 2000, Neurology.

[94]  H. Paulson,et al.  Mechanisms of chaperone suppression of polyglutamine disease: selectivity, synergy and modulation of protein solubility in Drosophila. , 2000, Human molecular genetics.

[95]  H. Zoghbi,et al.  Identification of genes that modify ataxin-1-induced neurodegeneration , 2000, Nature.

[96]  Michael S. Levine,et al.  Inactivation of Hdh in the brain and testis results in progressive neurodegeneration and sterility in mice , 2000, Nature Genetics.

[97]  Takanori Yamagata,et al.  Large expansion of the ATTCT pentanucleotide repeat in spinocerebellar ataxia type 10 , 2000, Nature Genetics.

[98]  R. J. White,et al.  Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat. , 2000, Science.

[99]  K. Fischbeck,et al.  CREB-binding protein sequestration by expanded polyglutamine. , 2000, Human molecular genetics.

[100]  P. Hagerman,et al.  Transcription of the FMR1 gene in individuals with fragile X syndrome. , 2000, American journal of medical genetics.

[101]  B. Byrne,et al.  Recruitment of human muscleblind proteins to (CUG)n expansions associated with myotonic dystrophy , 2000, The EMBO journal.

[102]  J. Nemes,et al.  The SCA8 transcript is an antisense RNA to a brain-specific transcript encoding a novel actin-binding protein (KLHL1). , 2000, Human molecular genetics.

[103]  D. Housman,et al.  The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[104]  S. Pulst,et al.  A novel protein with RNA-binding motifs interacts with ataxin-2. , 2000, Human molecular genetics.

[105]  K. Fischbeck,et al.  Inactivation of the Friedreich ataxia mouse gene leads to early embryonic lethality without iron accumulation. , 2000, Human molecular genetics.

[106]  John I. Clark,et al.  Mice deficient in Six5 develop cataracts: implications for myotonic dystrophy , 2000, Nature Genetics.

[107]  René Hen,et al.  Reversal of Neuropathology and Motor Dysfunction in a Conditional Model of Huntington's Disease , 2000, Cell.

[108]  Huda Y. Zoghbi,et al.  Polyglutamine expansion down-regulates specific neuronal genes before pathologic changes in SCA1 , 2000, Nature Neuroscience.

[109]  J. Skinner,et al.  Localization of the fragile X mental retardation 2 (FMR2) protein in mammalian brain , 2000, The European journal of neuroscience.

[110]  Melvin G McInnis,et al.  Expansion of a novel CAG trinucleotide repeat in the 5′ region of PPP2R2B is associated with SCA12 , 1999, Nature Genetics.

[111]  J. M. Boutell,et al.  Aberrant interactions of transcriptional repressor proteins with the Huntington's disease gene product, huntingtin. , 1999, Human molecular genetics.

[112]  F. Foury.  Low iron concentration and aconitase deficiency in a yeast frataxin homologue deficient strain , 1999, FEBS letters.

[113]  M. Delatycki,et al.  Direct evidence that mitochondrial iron accumulation occurs in Friedreich ataxia , 1999, Annals of neurology.

[114]  T. Bird,et al.  An untranslated CTG expansion causes a novel form of spinocerebellar ataxia (SCA8) , 1999, Nature Genetics.

[115]  C. Gellera,et al.  The Friedreich's ataxia mutation confers cellular sensitivity to oxidant stress which is rescued by chelators of iron and calcium and inhibitors of apoptosis. , 1999, Human molecular genetics.

[116]  Harry T Orr,et al.  Ataxin-1 Nuclear Localization and Aggregation Role in Polyglutamine-Induced Disease in SCA1 Transgenic Mice , 1998, Cell.

[117]  H. Zoghbi,et al.  Mice Lacking Ataxin-1 Display Learning Deficits and Decreased Hippocampal Paired-Pulse Facilitation , 1998, The Journal of Neuroscience.

[118]  T. Cooper,et al.  Disruption of splicing regulated by a CUG-binding protein in myotonic dystrophy. , 1998, Science.

[119]  D. Absher,et al.  FMRP associates with polyribosomes as an mRNP, and the I304N mutation of severe fragile X syndrome abolishes this association. , 1997, Molecular cell.

[120]  P Trouillas,et al.  Frataxin is reduced in Friedreich ataxia patients and is associated with mitochondrial membranes. , 1997, Human molecular genetics.

[121]  A. Munnich,et al.  Aconitase and mitochondrial iron–sulphur protein deficiency in Friedreich ataxia , 1997, Nature Genetics.

[122]  J. Gécz,et al.  Gene structure and subcellular localization of FMR2, a member of a new family of putative transcription activators. , 1997, Genomics.

[123]  É. Khandjian,et al.  The fragile X mental retardation protein is associated with poly(A)+ mRNA in actively translating polyribosomes. , 1997, Human molecular genetics.

[124]  F. Foury,et al.  Deletion of the yeast homologue of the human gene associated with Friedreich's ataxia elicits iron accumulation in mitochondria , 1997, FEBS letters.

[125]  R Greim,et al.  Exon/intron structure of the human AF‐4 gene, a member of the AF‐4/LAF‐4/FMR‐2 gene family coding for a nuclear protein with structural alterations in acute leukaemia , 1997, British journal of haematology.

[126]  M. Pandolfo,et al.  Regulation of mitochondrial iron accumulation by Yfh1p, a putative homolog of frataxin. , 1997, Science.

[127]  A. Taylor,et al.  Molecular-clinical correlations in males with an expanded FMR1 mutation. , 1996, American journal of medical genetics.

[128]  D. Housman,et al.  Mice lacking the myotonic dystrophy protein kinase develop a late onset progressive myopathy , 1996, Nature Genetics.

[129]  A. Berns,et al.  Abnormal myotonic dystrophy protein kinase levels produce only mild myopathy in mice , 1996, Nature Genetics.

[130]  R. Gibbs,et al.  Identification of FMR2, a novel gene associated with the FRAXE CCG repeat and CpG island , 1996, Nature Genetics.

[131]  J. Gécz,et al.  Identification of the gene FMR2, associated with FRAXE mental retardation , 1996, Nature Genetics.

[132]  P. Patel,et al.  Friedreich's Ataxia: Autosomal Recessive Disease Caused by an Intronic GAA Triplet Repeat Expansion , 1996, Science.

[133]  D. Loesch,et al.  FRAXE and mental retardation. , 1995, Journal of medical genetics.

[134]  K. Davies,et al.  Trinucleotide repeat amplification and hypermethylation of a CpG island in FRAXE mental retardation , 1993, Cell.

[135]  T. Ashizawa,et al.  An unstable triplet repeat in a gene related to myotonic muscular dystrophy. , 1992, Science.

[136]  C. Amemiya,et al.  Myotonic dystrophy mutation: an unstable CTG repeat in the 3' untranslated region of the gene. , 1992, Science.

[137]  David E. Housman,et al.  Molecular basis of myotonic dystrophy: Expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member , 1992, Cell.

[138]  K. Fischbeck,et al.  Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy , 1991, Nature.

[139]  J. Sutcliffe,et al.  Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome , 1991, Cell.

[140]  K. Au,et al.  Spinocerebellar ataxia type 6. , 2005, Hong Kong medical journal = Xianggang yi xue za zhi.

[141]  R. Llinás,et al.  Disturbed Ca 2 signaling and apoptosis of medium spiny neurons in Huntington ’ s disease , 2005 .

[142]  E. Nanba,et al.  [Myotonic dystrophy]. , 2005, Nihon rinsho. Japanese journal of clinical medicine.

[143]  C. Ross,et al.  Cell death triggered by polyglutamine-expanded huntingtin in a neuronal cell line is associated with degradation of CREB-binding protein. , 2003, Human molecular genetics.

[144]  D. Munoz.  Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X. , 2002, Neurology.

[145]  C. Ross,et al.  A repeat expansion in the gene encoding junctophilin-3 is associated with Huntington disease–like 2 , 2001, Nature Genetics.

[146]  R. Kopito,et al.  Impairment of the ubiquitin-proteasome system by protein aggregation. , 2001, Science.

[147]  H. Zoghbi,et al.  Glutamine repeats and neurodegeneration. , 2000, Annual review of neuroscience.

[148]  T. Godfrey,et al.  Elevated levels of FMR1 mRNA in carrier males: a new mechanism of involvement in the fragile-X syndrome. , 2000, American journal of human genetics.

[149]  L. Ranum,et al.  Genetic mapping of a second myotonic dystrophy locus , 1998, Nature Genetics.

[150]  Edwin Reyniers,et al.  A point mutation in the FMR-1 gene associated with fragile X mental retardation , 1993, Nature Genetics.

[151]  R. Lechtenberg.  Handbook of cerebellar diseases , 1993 .

[152]  Silverman,et al.  Fragile X Syndrome Diagnosis Treatment And Research , 2016 .

[153]  E. Hafen,et al.  Lilliputian : an AF 4 / FMR 2-related protein that controls cell identity and cell growth , 2022 .